TTC14 divergent transcript (TTC14-DT)

TTC14 divergent transcript (TTC14-DT) is presumed to be a non-coding RNA arising from divergent transcription at the promoter region of the *TTC14* gene, which encodes Tetratricopeptide Repeat Domain 14—a protein implicated in ciliary function[4]. Divergent transcripts such as TTC14-DT generally arise from bidirectional (sense and antisense) transcription at gene promoters and are often classified as long non-coding RNAs (lncRNAs)[1][3]. There is no evidence that TTC14-DT encodes a protein, acts as a receptor, enzyme, transporter, or is targeted by any known drugs. These transcripts are typically studied for their roles in gene regulation, but TTC14-DT itself has no documented biological function, disease association, or therapeutic relevance in current literature or genetic databases[4][5]. Key rationale for 'is_incorrect': - The term "divergent transcript" generally refers to a direction of transcription at a promoter, producing non-coding RNA antisense to a coding gene[1][3]. - There are no data supporting its role as a therapeutic target, nor as a molecule with defined biological or pathological roles[4][5]. - No known drugs act on this transcript, nor is there evidence of biomarker or safety relevance. - Its precise sequence, function, or any clinical connection is not described in publicly-available, curated scientific sources[4][5]. If you are seeking information about the protein-coding *TTC14* gene, please refer to Tetratricopeptide Repeat Domain 14 (TTC14)[4]. If you are interested in the general phenomenon of divergent transcription or lncRNAs, those are broad research topics with diverse implications, but "TTC14 divergent transcript" as an entity lacks structured characterization as a target.

Other names

TTC14-DT